50
Participants
Start Date
August 18, 2021
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
Buprenorphine/naloxone
Buprenorphine/naloxone is an opioid agonist treatment for opioid use disorder. It is administered via sublingual tablet form.
Hydromorphone
Hydromorphone is an opioid used for managing pain, craving, and withdrawal. It is administered orally via tablet or liquid form; or administered intravenously, subcutaneously, or intramuscularly via liquid form.
RECRUITING
Vancouver General Hospital, Vancouver
Vancouver Coastal Health
OTHER_GOV
University of British Columbia
OTHER